pET28a-SENP2 (catalytic domain) Citations (7)
Originally described in: Small ubiquitin-related modifier (SUMO)-specific proteases: profiling the specificities and activities of human SENPs.Mikolajczyk J, Drag M, Bekes M, Cao JT, Ronai Z, Salvesen GS J Biol Chem. 2007 Sep 7. 282(36):26217-24. PubMed Journal
Articles Citing pET28a-SENP2 (catalytic domain)
| Articles |
|---|
| The Cdc48 unfoldase prepares well-folded protein substrates for degradation by the 26S proteasome. Olszewski MM, Williams C, Dong KC, Martin A. Commun Biol. 2019 Jan 21;2:29. doi: 10.1038/s42003-019-0283-z. eCollection 2019. PubMed |
The 26S Proteasome Utilizes a Kinetic Gateway to Prioritize Substrate Degradation.
Bard JAM, Bashore C, Dong KC, Martin A.
Cell. 2019 Apr 4;177(2):286-298.e15. doi: 10.1016/j.cell.2019.02.031. Epub 2019 Mar 28.
PubMed
Associated Plasmids |
| A modular toolbox to generate complex polymeric ubiquitin architectures using orthogonal sortase enzymes. Fottner M, Weyh M, Gaussmann S, Schwarz D, Sattler M, Lang K. Nat Commun. 2021 Nov 11;12(1):6515. doi: 10.1038/s41467-021-26812-9. PubMed |
The Ufd1 cofactor determines the linkage specificity of polyubiquitin chain engagement by the AAA+ ATPase Cdc48.
Williams C, Dong KC, Arkinson C, Martin A.
Mol Cell. 2023 Mar 2;83(5):759-769.e7. doi: 10.1016/j.molcel.2023.01.016. Epub 2023 Feb 2.
PubMed
Associated Plasmids |
| Lactate regulates cell cycle by remodelling the anaphase promoting complex. Liu W, Wang Y, Bozi LHM, Fischer PD, Jedrychowski MP, Xiao H, Wu T, Darabedian N, He X, Mills EL, Burger N, Shin S, Reddy A, Sprenger HG, Tran N, Winther S, Hinshaw SM, Shen J, Seo HS, Song K, Xu AZ, Sebastian L, Zhao JJ, Dhe-Paganon S, Che J, Gygi SP, Arthanari H, Chouchani ET. Nature. 2023 Apr;616(7958):790-797. doi: 10.1038/s41586-023-05939-3. Epub 2023 Mar 15. PubMed |
| Alternating binding and p97-mediated dissociation of SDS22 and I3 recycles active PP1 between holophosphatases. Kueck AF, van den Boom J, Koska S, Ron D, Meyer H. Proc Natl Acad Sci U S A. 2024 Sep 3;121(36):e2408787121. doi: 10.1073/pnas.2408787121. Epub 2024 Aug 29. PubMed |
| AcrVIB1 inhibits CRISPR-Cas13b immunity by promoting unproductive crRNA binding accessible to RNase attack. Wandera KG, Schmelz S, Migur A, Kibe A, Lukat P, Achmedov T, Caliskan N, Blankenfeldt W, Beisel CL. Mol Cell. 2025 Mar 20;85(6):1162-1175.e7. doi: 10.1016/j.molcel.2025.01.020. Epub 2025 Feb 17. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.